Kaya (KAYS) & Its Peers Head-To-Head Survey

Kaya (OTCMKTS:KAYS) is one of 1,000 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it contrast to its rivals? We will compare Kaya to similar companies based on the strength of its risk, earnings, analyst recommendations, profitability, institutional ownership, dividends and valuation.

Institutional & Insider Ownership

44.7% of shares of all “Pharmaceutical preparations” companies are held by institutional investors. 23.5% of Kaya shares are held by company insiders. Comparatively, 14.2% of shares of all “Pharmaceutical preparations” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Earnings & Valuation

This table compares Kaya and its rivals revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
Kaya	$200,000.00	$1.61 million	-2.35
Kaya Competitors	$1.67 billion	$146.43 million	-1.64

Kaya’s rivals have higher revenue and earnings than Kaya. Kaya is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Analyst Recommendations

This is a breakdown of current ratings and target prices for Kaya and its rivals, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Kaya	0	0	0	0	N/A
Kaya Competitors	6390	18731	44645	917	2.57

As a group, “Pharmaceutical preparations” companies have a potential upside of 82.82%. Given Kaya’s rivals higher possible upside, analysts plainly believe Kaya has less favorable growth aspects than its rivals.

Profitability

This table compares Kaya and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Kaya	821.43%	-9.57%	638.26%
Kaya Competitors	-2,459.06%	-249.83%	-30.60%

Volatility and Risk

Kaya has a beta of 0.54, suggesting that its share price is 46% less volatile than the S&P 500. Comparatively, Kaya’s rivals have a beta of 1.09, suggesting that their average share price is 9% more volatile than the S&P 500.

Summary

Kaya rivals beat Kaya on 6 of the 10 factors compared.

About Kaya

Kaya Holdings, Inc., a vertically integrated legal cannabis enterprise, produces, distributes, and/or sells a range of cannabis products primarily in the United States. The company offers flower, oils, vape cartridges and cannabis infused confections, baked goods, and beverages. It also operates retail outlets under the Kaya Shack brand name, as well as offers strain specific cannabis cigarettes under the Kaya Buddies name, and strains of cannabis under the Kaya Farms name. In addition, the company provides standing display cases with cannabis intended glassware under the Really Happy Glass brand; and t-shirt designs under the Kaya Gear brand name. The company was formerly known as Alternative Fuels America, Inc. and changed its name to Kaya Holdings, Inc. in April 2015. Kaya Holdings, Inc. was incorporated in 1993 and is headquartered in Fort Lauderdale, Florida.